Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous IL-1 receptor antagonist to reduce inflammation after ischaemic stroke
2013-001757-28Phase 2Completed
- Sponsor
- Salford Royal NHS Foundation Trust
- Start
- Oct 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in ischemic stroke comparing Anakinra (Kineret) arm with Placebo arm (2 arms). Started Oct 2013; status: completed.
02
Drugs
anakinra
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2013-001757-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001757-28.